The expression and clinical significance of serum soluble programmed cell death ligand-1 in adult patients with community-acquired pneumonia

尚颖,高占成,贺新伟,赵丽丽,骆琼珍
DOI: https://doi.org/10.3760/cma.j.cn112138-20200306-00200
2021-01-01
Abstract:To investigate the clinical significance of serum soluble programmed cell death ligand-1 (PD-L1) in adult patients with community-acquired pneumonia (CAP). A total of 44 CAP patients, 54 severe CAP patients and 30 healthy volunteers were recruited in this study. Serum soluble PD-L1 were detected. Univariate and multivariate regression analyses were used to assess the influence of multiple clinical variables on prognosis. Serum soluble PD-L1 level in severe CAP group was 98.20(57.94, 128.90) ng/L, which was significantly higher than that in the CAP group [59.32(33.55, 92.58) ng/L] and healthy controls [20.44(12.15, 36.20) ng/L] (all <0.001). PD-L1 level was positively correlated with CRUB-65(=0.481, <0.001) and the pneumonia severity index (PSI) score (=0.442, <0.001). Univariate regression analysis showed that CURB-65 (=2.544, 95% 1.324-4.889, =0.005), PSI score (=1.036, 95% 1.012-1.061, =0.004), soluble PD-L1(=1.013, 95% 1.001-1.026, =0.041) were risk factors of mortality during hospitalization. Multivariate regression analysis suggested that PSI score (=1.042, 95% 1.012-1.073, =0.005), soluble PD-L1 (=1.011, 95% 1.002-1.071, =0.020) were independent predictors for mortality risk in CAP patients. CAP patients with soluble PD-L1≥98.20 ng/L had a significantly lower survival rate than those with soluble PD-L1<98.20 ng/L (=0.033). In conclusion, this study indicates that serum soluble PD-L1 level in CAP patients is correlated with the survival prognosis.
What problem does this paper attempt to address?